THE IMPACT OF MEDICAL AND ILLEGAL ABORTIONS ON WOMEN’S REPRODUCTIVE HEALTH

Authors

  • Naimova Zulfiya Abror qizi Bukhara University of Innovative Education and Medicine, Bukhara, Uzbekistan Author

Keywords:

abortion, medical abortion, mifepristone, misoprostol, reproductive health, contraception.

Abstract

This article analyzes the impact of medical and illegal (unsafe) abortions on women’s reproductive health on the basis of the scientific literature. It covers the effectiveness and safety criteria of medical abortion, its indications and contraindications, and its possible complications. The article shows that the combination of mifepristone and misoprostol yields high success rates in the early weeks of pregnancy, whereas unsafe abortion increases the risk of hemorrhage, purulent-inflammatory diseases, and secondary infertility. A separate section is devoted to post-abortion rehabilitation measures and the principles of contraceptive method selection. The author argues that providing abortion services under qualified medical supervision, offering women counseling beforehand, and promptly providing modern contraception after the abortion are the main prerequisites for reducing the number of repeat abortions.

References

1.Gulammaxmudova D.V., Samatova Y.B. Modern approaches to the termination of pregnancy (medical method) [in Uzbek] // Tashkent Medical Academy electronic repository (repo.tma.uz). — pp. 187–194.

2.Ziyayeva D.F. Early complications of abortion [in Uzbek] // Ilm Fan Xabarnomasi. — 2026. — Vol. 11(02). — pp. 890–895. — DOI: 10.5281/zenodo.18241886.

3.World Health Organization. Safe abortion: technical and policy guidance for health systems. 2nd ed. Geneva: WHO; 2012.

4.World Health Organization. Abortion care guideline. Geneva: WHO; 2022.

5.Ganatra B., Gerdts C., Rossier C., et al. Global, regional, and subregional classification of abortions by safety, 2010–14: estimates from a Bayesian hierarchical model // Lancet. — 2017. — Vol. 390(10110). — P. 2372–2381.

6.Raymond E.G., Shannon C., Weaver M.A., Winikoff B. First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review // Contraception. — 2013. — Vol. 87(1). — P. 26–37.

7.Winikoff B., Dzuba I.G., Chong E., et al. Extending outpatient medical abortion services through 70 days of gestational age // Obstet Gynecol. — 2012. — Vol. 120(5). — P. 1070–1076.

Downloads

Published

2026-10-06